Stem-cell-derived human microglia transplanted in mouse brain to study human disease.


Journal

Nature neuroscience
ISSN: 1546-1726
Titre abrégé: Nat Neurosci
Pays: United States
ID NLM: 9809671

Informations de publication

Date de publication:
12 2019
Historique:
received: 22 01 2019
accepted: 26 09 2019
pubmed: 30 10 2019
medline: 1 2 2020
entrez: 30 10 2019
Statut: ppublish

Résumé

Although genetics highlights the role of microglia in Alzheimer's disease, one-third of putative Alzheimer's disease risk genes lack adequate mouse orthologs. Here we successfully engraft human microglia derived from embryonic stem cells in the mouse brain. The cells recapitulate transcriptionally human primary microglia ex vivo and show expression of human-specific Alzheimer's disease risk genes. Oligomeric amyloid-β induces a divergent response in human versus mouse microglia. This model can be used to study the role of microglia in neurological diseases.

Identifiants

pubmed: 31659342
doi: 10.1038/s41593-019-0525-x
pii: 10.1038/s41593-019-0525-x
doi:

Substances chimiques

Amyloid beta-Peptides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2111-2116

Commentaires et corrections

Type : CommentIn

Références

Bohlen, C. J. et al. Diverse requirements for microglial survival, specification, and function revealed by defined-medium cultures. Neuron 94, 759–773.e8 (2017).
doi: 10.1016/j.neuron.2017.04.043
De Strooper, B. & Karran, E. The cellular phase of alzheimer’s disease. Cell 164, 603–615 (2016).
doi: 10.1016/j.cell.2015.12.056
Zerbino, D. R. et al. Ensembl 2018. Nucl. Acids Res. 46, D754–D761 (2018).
doi: 10.1093/nar/gkx1098
Jansen, I. E. & et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat. Genet. 51, 404–413 (2019).
doi: 10.1038/s41588-018-0311-9
Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452–1458 (2013).
doi: 10.1038/ng.2802
Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat. Genet. 51, 414–430 (2019).
doi: 10.1038/s41588-019-0358-2
Claes, C. & et al. Human stem cell–derived monocytes and microglia-like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2. Alzheimers Dement. 15, 453–464 (2019).
doi: 10.1016/j.jalz.2018.09.006
Rathinam, C. et al. Efficient differentiation and function of human macrophages in humanized CSF-1 mice. Blood 118, 3119–3128 (2011).
doi: 10.1182/blood-2010-12-326926
Hagemeyer, N. et al. Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood. Acta Neuropathol. 134, 441–458 (2017).
doi: 10.1007/s00401-017-1747-1
Davis, B. M., Salinas-Navarro, M., Cordeiro, M. F., Moons, L. & Groef, L. De. Characterizing microglia activation: a spatial statistics approach to maximize information extraction. Sci. Rep. 7, 1–12 (2017).
doi: 10.1038/s41598-016-0028-x
Jordão, M. J. C. et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science 363, eaat7554 (2019).
doi: 10.1126/science.aat7554
Sala Frigerio, C. et al. The major risk factors for Alzheimer’s disease: age, sex, and genes modulate the microglia response to Aβ plaques. Cell Rep. 27, 1293–1306.e6 (2019).
doi: 10.1016/j.celrep.2019.03.099
Friedman, B. A. et al. Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of alzheimer’s disease not evident in mouse models. Cell Rep. 22, 832–847 (2018).
doi: 10.1016/j.celrep.2017.12.066
Brouillette, J. et al. Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1-42 oligomers are revealed in vivo by using a novel animal model. J. Neurosci. 32, 7852–7861 (2012).
doi: 10.1523/JNEUROSCI.5901-11.2012
Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381–386 (2014).
doi: 10.1038/nbt.2859
Keren-Shaul, H. et al. A unique microglia type associated with restricting development of alzheimer’s disease. Cell 169, 1276–1290.e17 (2017).
doi: 10.1016/j.cell.2017.05.018
Marsh, S. E. et al. The adaptive immune system restrains Alzheimer’s disease pathogenesis by modulating microglial function. Proc. Natl. Acad. Sci. USA 113, E1316–E1325 (2016).
doi: 10.1073/pnas.1525466113
Shay, T. et al. Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc. Natl. Acad. Sci. USA 110, 2946–2951 (2013).
doi: 10.1073/pnas.1222738110
Butovsky, O. et al. Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat. Neurosci. 17, 131–143 (2014).
doi: 10.1038/nn.3599
Bhaskar, K. et al. Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68, 19–31 (2010).
doi: 10.1016/j.neuron.2010.08.023
Deshmane, S. L., Kremlev, S., Amini, S. & Sawaya, B. E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 29, 313–326 (2009).
doi: 10.1089/jir.2008.0027
Abud, E. M. et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94, 278–293.e9 (2017).
doi: 10.1016/j.neuron.2017.03.042
Espuny-Camacho, I. et al. Hallmarks of Alzheimer’s disease in stem-cell-derived human neurons transplanted into mouse brain. Neuron 93, 1066–1081.e8 (2017).
doi: 10.1016/j.neuron.2017.02.001
Kuperstein, I. et al. Neurotoxicity of Alzheimer’s disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio. EMBO J. 29, 3408–3420 (2010).
doi: 10.1038/emboj.2010.211
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902.e21 (2019).
doi: 10.1016/j.cell.2019.05.031
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
doi: 10.1038/nbt.4096
Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979–982 (2017).
doi: 10.1038/nmeth.4402
Eden, E., Navon, R., Steinfeld, I., Lipson, D. & Yakhini, Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinform. 10, 1–7 (2009).
doi: 10.1186/1471-2105-10-48

Auteurs

Renzo Mancuso (R)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium. renzo.mancuso@kuleuven.vib.be.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium. renzo.mancuso@kuleuven.vib.be.

Johanna Van Den Daele (J)

Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.
Department of Development and Regeneration, Stem Cell Biology and Embryology, KU Leuven Stem Cell Institute, Leuven, Belgium.

Nicola Fattorelli (N)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.

Leen Wolfs (L)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.

Sriram Balusu (S)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.

Oliver Burton (O)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.

Adrian Liston (A)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.

Annerieke Sierksma (A)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.

Yannick Fourne (Y)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.

Suresh Poovathingal (S)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.

Amaia Arranz-Mendiguren (A)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.

Carlo Sala Frigerio (C)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.

Christel Claes (C)

Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.
Department of Development and Regeneration, Stem Cell Biology and Embryology, KU Leuven Stem Cell Institute, Leuven, Belgium.

Lutgarde Serneels (L)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.

Tom Theys (T)

Department of Neurosciences, Research Group Experimental Neurosurgery and Neuroanatomy, KU Leuven, Leuven, Belgium.

V Hugh Perry (VH)

UK Dementia Research Institute at UCL, University College London, London, UK.

Catherine Verfaillie (C)

Department of Development and Regeneration, Stem Cell Biology and Embryology, KU Leuven Stem Cell Institute, Leuven, Belgium.

Mark Fiers (M)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium.

Bart De Strooper (B)

Centre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium. bart.destrooper@kuleuven.vib.be.
Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven, Belgium. bart.destrooper@kuleuven.vib.be.
UK Dementia Research Institute at UCL, University College London, London, UK. bart.destrooper@kuleuven.vib.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH